Literature DB >> 13183773

Syndrome simulating acute disseminated lupus erythematosus: appearance after hydralazine (apresoline) therapy.

N H SHACKMAN, A I SWILLER, M MORRISON.   

Abstract

Entities:  

Keywords:  LUPUS ERYTHEMATOSUS/differential diagnosis; SYMPATHOLYTICS/injurious effects

Mesh：

Substances：

Year:  1954        PMID： 13183773     DOI： 10.1001/jama.1954.73690350002010a

Source DB:  PubMed          Journal:  J Am Med Assoc        ISSN： 0002-9955


× No keyword cloud information.
  6 in total

1.  [Incidence of leukocyte agglutinating antibodies and thrombocytic antibodies in a case of acute disseminated lupus erythematosus].

Authors:  W MULLER; B RADOJICIC
Journal:  Klin Wochenschr       Date:  1956-06-01

2.  The L.E. (lupus erythematosus) cell reaction.

Authors:  M A OGRYZLO
Journal:  Can Med Assoc J       Date:  1956-12-15       Impact factor: 8.262

3.  Lupus erythematosus cells in systemic sclerosis.

Authors:  N R ROWELL
Journal:  Ann Rheum Dis       Date:  1962-03       Impact factor: 19.103

4.  Successful use of rituximab for hydralazine-induced anti-neutrophil cytoplasmic antibodies-associated vasculitis.

Authors:  Michael A Paley; Fahad Edrees; Satoru Kudose; Joseph P Gaut; Prabha Ranganathan; Anitha Vijayan
Journal:  Saudi J Kidney Dis Transpl       Date:  2019 Jan-Feb

5.  Collagen prolyl hydroxylation in WI-38 fibroblast cultures: action of hydralazine.

Authors:  K H Chen; M A Paz; P M Gallop
Journal:  In Vitro       Date:  1977-01

6.  The clinical evaluation and management of hypertension.

Authors:  A V GOODYER; E ROSENTHAL; C A JAEGER
Journal:  Yale J Biol Med       Date:  1955-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.